E-Updates
Controversies in Preoperative Chemoradiation for Rectal Cancer
May 2009
Targeted Therapies for Colorectal Cancer in the Adjuvant Setting: Are You Already Doing This Without the Data?
October 2008
Molecularly Targeted Therapy for Metastatic Colon Cancer: Proven Treatments and Promising New Agents
August 2008
Dual EGFR/VEGF: Asked and Answered, or Did We Ask the Wrong Question?
June 2008
Mutated ras as a Predictor of Response: Is It Ready for the Clinic?
May 2008
Current and Future Roles of Lapatinib in HER2-Positive Breast Cancer
September 2008
Optimal Chemotherapy Combinations with Trastuzumab: Are Anthracyclines Obsolete?
July 2008
Anti-HER2/neu Therapy: Is Adjuvant Trastuzumab for All HER2-Positive Breast Cancer Regardless of Tumor Characteristics?
May 2008
Advances in Basic Biology of HER2 Targeting
April 2008
Molecular Profiling for Cytotoxics and Targeted Agents: Ready for Prime Time?
December 2008
Practical Approach to the Treatment of Locally Advanced NSCLC: Controversies in Systemic Therapy
November 2008
Surgery for Stage III NSCLC—Who, When, What, and How?
August 2008
Current Status of Adjuvant Therapy in Non-Small Cell Lung Cancer
July 2008
